108 related articles for article (PubMed ID: 16168109)
21. Effect of Propofol on breast Cancer cell, the immune system, and patient outcome.
Li R; Liu H; Dilger JP; Lin J
BMC Anesthesiol; 2018 Jun; 18(1):77. PubMed ID: 29945542
[TBL] [Abstract][Full Text] [Related]
22. Propofol Inhibits HeLa Cells by Impairing Autophagic Flux via AMP-Activated Protein Kinase (AMPK) Activation and Endoplasmic Reticulum Stress Regulated by Calcium.
Chen X; Li K; Zhao G
Med Sci Monit; 2018 Apr; 24():2339-2349. PubMed ID: 29667627
[TBL] [Abstract][Full Text] [Related]
23. Propofol enhances BCR-ABL TKIs' inhibitory effects in chronic myeloid leukemia through Akt/mTOR suppression.
Tan Z; Peng A; Xu J; Ouyang M
BMC Anesthesiol; 2017 Sep; 17(1):132. PubMed ID: 28962554
[TBL] [Abstract][Full Text] [Related]
24. Cell membrane modulation as adjuvant in cancer therapy.
Zalba S; Ten Hagen TL
Cancer Treat Rev; 2017 Jan; 52():48-57. PubMed ID: 27889637
[TBL] [Abstract][Full Text] [Related]
25. Propofol suppresses proliferation and invasion of glioma cells by upregulating microRNA-218 expression.
Xu J; Xu W; Zhu J
Mol Med Rep; 2015 Oct; 12(4):4815-20. PubMed ID: 26133092
[TBL] [Abstract][Full Text] [Related]
26. Biophysical Interactions of Novel Oleic Acid Conjugate and its Anticancer Potential in HeLa Cells.
Khan AA; Alanazi AM; Jabeen M; Parvez MK; Wahab R; Abdelhameed AS; Chauhan A
J Fluoresc; 2015 May; 25(3):519-25. PubMed ID: 25638605
[TBL] [Abstract][Full Text] [Related]
27. Mini profile of potential anticancer properties of propofol.
Song J; Shen Y; Zhang J; Lian Q
PLoS One; 2014; 9(12):e114440. PubMed ID: 25502773
[TBL] [Abstract][Full Text] [Related]
28. Metformin-induced killing of triple-negative breast cancer cells is mediated by reduction in fatty acid synthase via miRNA-193b.
Wahdan-Alaswad RS; Cochrane DR; Spoelstra NS; Howe EN; Edgerton SM; Anderson SM; Thor AD; Richer JK
Horm Cancer; 2014 Dec; 5(6):374-89. PubMed ID: 25213330
[TBL] [Abstract][Full Text] [Related]
29. Effect of opiates, anesthetic techniques, and other perioperative factors on surgical cancer patients.
Kaye AD; Patel N; Bueno FR; Hymel B; Vadivelu N; Kodumudi G; Urman RD
Ochsner J; 2014; 14(2):216-28. PubMed ID: 24940132
[TBL] [Abstract][Full Text] [Related]
30. Choice of anesthetic technique on plasma concentrations of interleukins and cell adhesion molecules.
Ionescu DC; Margarit SC; Hadade AN; Mocan TN; Miron NA; Sessler DI
Perioper Med (Lond); 2013 May; 2(1):8. PubMed ID: 24472144
[TBL] [Abstract][Full Text] [Related]
31. Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells in vitro by inhibition of nuclear factor-κB activity.
Du QH; Xu YB; Zhang MY; Yun P; He CY
World J Gastroenterol; 2013 Sep; 19(33):5485-92. PubMed ID: 24023491
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and characterization of novel n-9 fatty acid conjugates possessing antineoplastic properties.
Khan AA; Husain A; Jabeen M; Mustafa J; Owais M
Lipids; 2012 Oct; 47(10):973-86. PubMed ID: 22923370
[TBL] [Abstract][Full Text] [Related]
33. In vivo effects of different anesthetic agents on apoptosis.
Osman ES; Khafagy HF; Samhan YM; Hassan MM; El-Shanawany FM; Fathallah AR; El-Fandy GG
Korean J Anesthesiol; 2012 Jul; 63(1):18-24. PubMed ID: 22870360
[TBL] [Abstract][Full Text] [Related]
34. Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer.
Nomura DK; Lombardi DP; Chang JW; Niessen S; Ward AM; Long JZ; Hoover HH; Cravatt BF
Chem Biol; 2011 Jul; 18(7):846-56. PubMed ID: 21802006
[TBL] [Abstract][Full Text] [Related]
35. Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol.
Inada T; Kubo K; Shingu K
J Anesth; 2011 Aug; 25(4):569-75. PubMed ID: 21611862
[TBL] [Abstract][Full Text] [Related]
36. Minerval induces apoptosis in Jurkat and other cancer cells.
Llado V; Gutierrez A; Martínez J; Casas J; Terés S; Higuera M; Galmés A; Saus C; Besalduch J; Busquets X; Escribá PV
J Cell Mol Med; 2010 Mar; 14(3):659-70. PubMed ID: 19413889
[TBL] [Abstract][Full Text] [Related]
37. Anticancer properties of propofol-docosahexaenoate and propofol-eicosapentaenoate on breast cancer cells.
Siddiqui RA; Zerouga M; Wu M; Castillo A; Harvey K; Zaloga GP; Stillwell W
Breast Cancer Res; 2005; 7(5):R645-54. PubMed ID: 16168109
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
Schley PD; Jijon HB; Robinson LE; Field CJ
Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of low-dose docosahexaenoic acid and eicosapentaenoic acid on the regulation of mitogenic signaling pathways in mesangial cells.
Yusufi AN; Cheng J; Thompson MA; Walker HJ; Gray CE; Warner GM; Grande JP
J Lab Clin Med; 2003 May; 141(5):318-29. PubMed ID: 12761475
[TBL] [Abstract][Full Text] [Related]
40. [Role of Rho GTPase in inhibiting metastatic ability of human prostate cancer cell line PC-3 by omega-3 polyunsaturated fatty acid].
Yi L; Zhang QY; Mi MT
Ai Zheng; 2007 Dec; 26(12):1281-6. PubMed ID: 18076787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
